Benefit Of Abiraterone Acetate Plus Prednisone (AA+P) Added To Androgen Deprivation Therapy (ADT) In Patients With High-Risk, Newly Diagnosed Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): Post Hoc Analysis Of EQ-5D-5L From The Latitude Study
暂无分享,去创建一个
K. Fizazi | K. Chi | H. Metin | J. Diels | G. Sulur | Tracy Li | K. McQuarrie | P. Thilakarathne | T. Ito